Manke Isaac

Manke Isaac is listed in filings as Director at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including 14 public disclosures. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR) and Q32 Bio Inc. (QTTB). The current snapshot covers public activity from Oct 8, 2024 to Jan 2, 2026. Reported amounts are shown as $149.9K to $214.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.